Excellence in life sciences executive search

Esperion Therapeutics Retains The Chase Group to Fill Chief Commercial Officer Role

April 7, 2017
Esperion Therapeutics has retained The Chase Group to secure a Chief Commercial Officer to provide the leadership, strategic vision, and functional expertise to drive the company to successful commercialization of the company’s LDL-C lowering therapies. This executive leader will have demonstrated success in building a commercial organization and launching products that significantly impact patients’ lives. For confidential consideration, contact Bonnie at bonnie@chasegroup.com.

Chase Group

Share this Content

Copyright © 1993-2024 The Chase Group. All Rights Reserved.